Sodium tanshinone IIA sulfonate for pulmonary arterial hypertension: emerging therapeutic option
- PMID: 23585934
- PMCID: PMC3621921
- DOI: 10.3978/j.issn.2072-1439.2013.02.05
Sodium tanshinone IIA sulfonate for pulmonary arterial hypertension: emerging therapeutic option
References
-
- Raja SG. Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension. Recent Pat Cardiovasc Drug Discov 2012;7:100-4 - PubMed
-
- Raja SG. Endothelin receptor antagonists for pulmonary arterial hypertension: an overview. Cardiovasc Ther 2010;28:e65-71 - PubMed
-
- Raja SG, Danton MD, MacArthur KJ, et al. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence. J Cardiothorac Vasc Anesth 2006;20:722-35 - PubMed
-
- Raja SG, Nayak SH. Sildenafil: emerging cardiovascular indications. Ann Thorac Surg 2004;78:1496-506 - PubMed
LinkOut - more resources
Full Text Sources